Lawmakers struggle towards insurance coverage discrimination for Naloxone

BOSTON (WWLP) – The monetary Providers Committee this week heard testimony on a invoice that may take away penalties that insurance coverage corporations have for individuals who buy the life-saving drug, Naloxone.

Naloxone, formally referred to as Narcan is a drugs designed to reverse an opioid overdose. It could possibly virtually instantaneously revive somebody whose respiration has slowed or stopped, because of overdosing on heroin or prescription ache medicines.


When the invoice’s sponsor, Senator Joan Pretty witnessed an overdose whereas grocery buying she felt compelled to hold Narcan, however she by no means anticipated operating into points along with her insurance coverage firm.

“After which this Physician instructed me about this example the place the insurance coverage coverage was canceled because of him filling a script for Narcan,” Sen. Pretty mentioned.

Senator Pretty filed Senate Invoice 24-16 to verify nobody else is discriminated towards by their insurance coverage firm for having a Naloxone prescription.


“There’s discrimination towards individuals who have that prescription and so her invoice is absolutely crucial that we cross in order that individuals are getting the healthcare that they want,” Rep. Sabadosa mentioned.

Proper now, Massachusetts residents should buy a two-dose equipment of Narcan for about $30, however it may value them much more than that in the long term.

Employers throughout the commonwealth are additionally working to make their firm’s extra restoration pleasant, a transfer that lawmakers wish to see occur throughout the insurance coverage trade as properly.